Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Micafungin Sodium

Brands: Micafungin · Mycamine · Micafungin Sodium

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)325887
US makers5 labelers
Packages16
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.6K3.1K4.7K6.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.2K
Rx · 2026 Q1
17K
Units dispensed
-14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sagent Pharmaceuticalsunknown6SUPPLYING
Meitheal Pharmaceuticals Inc.unknown4SUPPLYING
Fresenius Kabi USA, LLCunknown3SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
Astellas Pharma US, Inc.unknown1EXITED 2026

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 22, 2018
    RECALLRecall (Class II): Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbr…

    Labeling: Label Error on Declared Strength — Recalling firm: Astellas Pharma US Inc — Nationwide.